Oral Oncology
Volume 38, Issue 8 , Pages 785-792, December 2002

Osteosarcoma arising in Paget's disease of the mandible

  • Yi-Shing Lisa Cheng

      Affiliations

    • Diagnostic Sciences, Baylor College of Dentistry-TAMUSHSC, 3302 Gaston Avenue, Dallas, TX 75246, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-214-8288912/7506955; fax: +1-214-8288306
  • ,
  • John M. Wright

      Affiliations

    • Diagnostic Sciences, Baylor College of Dentistry-TAMUSHSC, 3302 Gaston Avenue, Dallas, TX 75246, USA
  • ,
  • William R. Walstad

      Affiliations

    • Oral and Maxillofacial Surgery, Baylor College of Dentistry-TAMUSHSC, 3302 Gaston Avenue, Dallas, TX 75246, USA
  • ,
  • Maxwell D. Finn

      Affiliations

    • Oral and Maxillofacial Surgery, Baylor College of Dentistry-TAMUSHSC, 3302 Gaston Avenue, Dallas, TX 75246, USA

Received 11 June 2002; accepted 10 July 2002.

Abstract 

Although osteosarcoma is a well-known complication of Paget's disease of bone, it uncommonly develops in the jaw bones. We present an osteosarcoma arising in Paget's disease of the mandible with unique features of a normal serum alkaline phosphatase level, and histologic features of telangiectatic change in the osteosarcoma and association with cemento-osseous dysplasia. Sixteen reported cases of osteosarcoma arising in Paget's disease of the jaw bones (OPJ) are also reviewed and compared to osteosarcoma arising in Paget's disease occurring in the entire skeleton (OPS) and osteosarcoma arising de novo in the jaw bones (OJ). Females are more commonly involved in OPJ in contrast to a male predominance in OPS and OJ. OPJ also has a distinctively higher percentage involving blacks compared to OPS. The prognosis of OPJ is poor, with 69% of patients dying within two years after diagnosis. Early recognition, early and aggressive treatment are important to improve the prognosis and are hence emphasized.

Keywords:  Osteosarcoma, Paget's disease of bone, Jaw

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(02)00065-9

doi:10.1016/S1368-8375(02)00065-9

Oral Oncology
Volume 38, Issue 8 , Pages 785-792, December 2002